Last reviewed · How we verify

Use of cannabis oil

Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria · Phase 2 active Small molecule

Use of cannabis oil is a Small molecule drug developed by Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria. It is currently in Phase 2 development.

At a glance

Generic nameUse of cannabis oil
SponsorAzienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Use of cannabis oil

What is Use of cannabis oil?

Use of cannabis oil is a Small molecule drug developed by Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria.

Who makes Use of cannabis oil?

Use of cannabis oil is developed by Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria (see full Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria pipeline at /company/azienda-ospedaliera-ss-antonio-e-biagio-e-cesare-arrigo-di-alessandria).

What development phase is Use of cannabis oil in?

Use of cannabis oil is in Phase 2.

Related